 |  |  |
| Jaap Jan Boelens, MD, PhD ISCT 2021 Co-Chair Memorial Sloan Kettering Cancer Center New York, United States | Karen Nichols, Esq. ISCT 2021 Co-Chair Vertex Therapeutics Cambridge, United States | George Muschler, MD ISCT 2021 Co-Chair Cleveland Clinic Cleveland, United States |
| Julie Allickson, PhD Wake Forest Institute of Regenerative Medicine Winston-Salem, United States | Patricia Rocco, MD, PhD Federal University of Rio de Janeiro Rio de Janeiro, Brazil |
| Lizette Caballero, BS, MT(ASCP) Janssen Research & Development San Francisco, United States | Joseph (Yossi) Schwartz, MD, MPH Weill Cornell Medicine New York, United States |
| Dominic Clarke, PhD HemaCare Corporation Durham, United States | Sandeep Soni, MD CRISPR Therapeutics San Francisco, United States |
| Patrick Hanley, PhD Children’s National Hospital Washington, United States | Jacques Galipeau, MD University of Wisconsin-Madison Madison, United States |
| Sai-Kiang Lim, PhD Institute of Molevular & Cell Biology Singapore, Singapore | Bruce Levine, PhD University of Pennsylvania Philadelphia, United States |
| Giuseppe Orlando, MD, PhD Wake Forest University Winston-Salem, United States | Daniel Weiss, MD, PhD University of Vermont School of Medicine Burlington, United States |
Call for Abstract Submissions
Abstract submission now open • Submission Deadline: January 25th, 2021
Join ISCT, the leading global society focused on the translation of cell and gene therapy, at the ISCT 2021 New Orleans VIRTUAL Meeting.
Why submit your abstract to ISCT 2021?
With record breaking attendance, ISCT 2020 Paris Virtual hosted over 2,000 experts from around the world. Abstracts presented at the event were viewed over 17,000 times. Don’t miss this opportunity to maximize the visibility and reach of your work.
Emphasizing the translational focus of ISCT, new abstract subcategories include:
ISCT 2021 New Orleans Virtual Abstract Categories:
Fill in this form to be added to our pre-event mailing list!
More information will be available soon through our websites, our e-mail distribution, and through social media.
I am writing to share that ISCT has made the decision to host the ISCT 2021 New Orleans Annual Meeting in a virtual setting. While we very much look forward to the day we can gather again face to face, we continue to monitor the COVID-19 pandemic and have concluded that the most responsible course of action is to gather virtually for our 2021 Annual Meeting.
Both our Society and the entire cell and gene therapy field have shown remarkable resilience this year. You might have heard that ISCT 2020 Paris Virtual had record breaking attendance with over 2,000 delegates joining us from 60 countries. We have also experienced record-breaking ISCT membership growth this year and are now proud to represent more than 2,400 members from around the world.
In that spirit, and as we follow up on unprecedented growth, the New Orleans Virtual Meeting tagline has a slight twist to it: Re-Connect, Communicate, Translate. More than ever, we have a chance to broadcast the passion and excitement that characterizes our Society to one another, and to the global stage.
The ISCT 2021 Organizing Committee has kicked off development of the scientific program which will span 3 full live days, from May 26-28, 2021. This year, you can look forward to a full production showcasing sessions with world class scientific, regulatory and commercial experts, from the comfort of your home or office. With this are more opportunities than ever to showcase our corporate partners and advancements in the cell and gene therapy market through engaging presentations.
I’d like to thank all who responded to our 2021 pre-meeting survey. Networking with fellow delegates was identified as the most important motive for attending the 2021 Annual Meeting, and we’re already underway to deliver. We are working behind the scenes to set the bar even higher this year with new ways to engage with fellow meeting delegates in-platform and on social media.
More than ever, it’s important to stay connected.
Keep an eye out for more information, coming soon to social media, to your inboxes, and to www.isct2021.com
Sincerely,
Bruce Levine, PhD
President, 2020-2022
ISCT, International Society for Cell & Gene Therapy
ISCT is actively monitoring the current COVID-19 pandemic and working to
expand the presentation and sponsorship opportunities for ISCT 2021.
Contact us to discuss your planning needs and stay tuned for the
release of the 2021 Corporate Prospectus and Booking form.
Madeline St. Onge
Associate Director, Marketing & Industry Affairs
Madeline@isctglobal.org
Simone Stickland
Coordinator, Outreach & Business Development
simone@isctglobal.org
Placeholder for Abstracts
